DM Clinical Research Founder & CEO Mohammad Millwala. “DM Clinical Research is committed to making participation in clinical trials accessible to a broader, more diverse population base. In 2022, minority enrollment for all of our studies was more than 49%. The Boston site enhances our ability to offer research sponsors access to a diverse patient footprint that already includes underserved communities in Chicago, Detroit, Houston and Philadelphia.”